EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

Validation and clinical application of the hereditary hemorrhagic telangiectasia-specific quality of life scale

Hanny Al-Samkari, Raj S Kasthuri, Vivek N Iyer, Allyson M Pishko, Jake E Decker, Clifford R Weiss, Kevin J Whitehead, Miles B Conrad, Marc S Zumberg, Jenny Y Zhou, Joseph Parambil, Benjamin Carper und 3 weitere

Journal of Thrombosis and Haemostasis · 2026

DOI: 10.1016/j.jtha.2025.09.024 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026. Verfasst von Hanny Al-Samkari und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: hal-samkari@…. Hauptthemen laut MEDLINE: Quality of Life, Telangiectasia, Hereditary Hemorrhagic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Heart Lung and Blood Institute, Alnylam Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeTelangiectasia, Hereditary HemorrhagicHumansFemaleMaleMiddle AgedReproducibility of ResultsSurveys and QuestionnairesAdultEpistaxisSeverity of Illness IndexAgedLongitudinal Studies

Stichwörter der Autor:innen

anemiableedingepistaxishereditary hemorrhagic telangiectasiaquality of life

Autor:innen und Institutionen

  • Division of Hematology Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: hal-samkari@mgh.harvard.edu.
  • Division of Hematology/Oncology, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Division of Pulmonary/Critical Care, Mayo Clinic, Rochester, Minnesota, USA.
  • Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Internal Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Department of Radiology, Johns Hopkins University, Baltimore, Maryland, USA.

Förderung

  • NHLBI NIH HHS
  • National Heart Lung and Blood Institute
  • Alnylam Pharmaceuticals
  • U.S. Department of Defense
  • Health Resources and Services Administration

Zitieren

APA

Al-Samkari, H., Kasthuri, R. S., Iyer, V. N., Pishko, A. M., Decker, J. E., Weiss, C. R., Whitehead, K. J., Conrad, M. B., Zumberg, M. S., Zhou, J. Y., Parambil, J., Carper, B., Clancy, M., Thomas, S. M., & McCrae, K. R. (2026). Validation and clinical application of the hereditary hemorrhagic telangiectasia-specific quality of life scale. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2025.09.024

Vancouver

Al-Samkari H, Kasthuri RS, Iyer VN, Pishko AM, Decker JE, Weiss CR, et al. Validation and clinical application of the hereditary hemorrhagic telangiectasia-specific quality of life scale. Journal of Thrombosis and Haemostasis. 2026. doi:10.1016/j.jtha.2025.09.024

BibTeX
@article{AlSamkari2026,
  author = {Al-Samkari, Hanny and Kasthuri, Raj S and Iyer, Vivek N and Pishko, Allyson M and Decker, Jake E and Weiss, Clifford R and Whitehead, Kevin J and Conrad, Miles B and Zumberg, Marc S and Zhou, Jenny Y and Parambil, Joseph and Carper, Benjamin and Clancy, Marianne and Thomas, Sonia M and McCrae, Keith R},
  title = {Validation and clinical application of the hereditary hemorrhagic telangiectasia-specific quality of life scale},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2026},
  doi = {10.1016/j.jtha.2025.09.024}
}
Kostenlos starten →